Země: Velká Británie
Jazyk: angličtina
Zdroj: VMD (Veterinary Medicines Directorate)
Boric Acid, Calcium
Norbrook Laboratories Limited
QA12AX
Boric Acid, Calcium
Expired
Revised: 19 May 2009 AN: 00113/2008 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Norcal 40 Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 400ml vial contains: ACTIVE SUBSTANCE: 11.88g Calcium provided by Calcium Gluconate and Calcium Borogluconate. Also contains 6.5% w/v Boric Acid. For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. A clear pale, yellow liquid. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of hypocalcaemia. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE (I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS The solution should be warmed to body temperature before administration. Intravenous injections should be given slowly. Observe aseptic precautions. See also warning under 6.4 (II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Care should be taken to avoid accidental self injection: may cause irritation at site of injection Revised: 19 May 2009 AN: 00113/2008 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Provided the recommendations are followed carefully, undesirable effects should not occur. 4.7 USE DURING PREGNANCY AND LACTATION Norcal 40 can be safely administered to pregnant and lactating animals. 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION No known interactions. 4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE Administer by subcutaneous or slow intravenous injection at the following rate: Cattle: 150 - 500 ml 4.10 OVERDOSE (SYMPTOMS, EMERGENCY PROCEDURES, ANTIDOTES), IF NECESSARY Not applicable. 4.11 WITHDRAWAL PERIOD(S) Meat – Zero days Milk – Zero hours 5. PHARMACOLOGICAL PROPERTIES PHARMACOTHERAPEUTIC GROUP: MINERAL SUPPLEMENT ATC VET CODE: QA12AX 5.1 PHARMACODYNAMIC PROPERTIES Milk fever which is characterised by hypocalcaemia is caused by an acute drop Přečtěte si celý dokument